IRIS
ROGLIANI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 77.897
AS - Asia 12.928
EU - Europa 8.651
SA - Sud America 1.924
AF - Africa 172
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 24
Totale 101.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 77.578
SG - Singapore 6.235
CN - Cina 2.339
BR - Brasile 1.596
IT - Italia 1.536
RU - Federazione Russa 1.417
HK - Hong Kong 1.301
VN - Vietnam 1.074
IE - Irlanda 1.053
DE - Germania 883
UA - Ucraina 809
FR - Francia 750
KR - Corea 750
PL - Polonia 511
GB - Regno Unito 502
FI - Finlandia 395
JP - Giappone 366
SE - Svezia 242
NL - Olanda 192
CA - Canada 167
IN - India 160
ID - Indonesia 130
AR - Argentina 111
BD - Bangladesh 90
MX - Messico 86
IQ - Iraq 73
ES - Italia 71
AT - Austria 69
ZA - Sudafrica 57
PK - Pakistan 49
TR - Turchia 49
CO - Colombia 45
EC - Ecuador 43
AU - Australia 41
BE - Belgio 41
CL - Cile 35
EG - Egitto 32
TW - Taiwan 32
UZ - Uzbekistan 32
VE - Venezuela 31
PH - Filippine 29
MY - Malesia 27
PE - Perù 25
SA - Arabia Saudita 24
GR - Grecia 20
PT - Portogallo 20
RO - Romania 20
IL - Israele 19
MA - Marocco 19
PY - Paraguay 19
CZ - Repubblica Ceca 17
JO - Giordania 17
KE - Kenya 17
LT - Lituania 17
TH - Thailandia 16
TN - Tunisia 16
AE - Emirati Arabi Uniti 15
AL - Albania 14
IR - Iran 12
UY - Uruguay 12
A2 - ???statistics.table.value.countryCode.A2??? 11
CR - Costa Rica 11
JM - Giamaica 11
NP - Nepal 11
EU - Europa 10
KZ - Kazakistan 10
BH - Bahrain 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
PA - Panama 9
CH - Svizzera 8
KG - Kirghizistan 8
LB - Libano 8
AZ - Azerbaigian 7
BG - Bulgaria 7
DK - Danimarca 7
ET - Etiopia 7
HR - Croazia 7
TT - Trinidad e Tobago 7
HU - Ungheria 6
BO - Bolivia 5
LV - Lettonia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
KH - Cambogia 4
KW - Kuwait 4
LY - Libia 4
MK - Macedonia 4
OM - Oman 4
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
CY - Cipro 3
EE - Estonia 3
LK - Sri Lanka 3
NO - Norvegia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 101.598
Salva come PNG Salva come JPEG
Città #
Wilmington 19.879
Houston 18.368
Woodbridge 18.105
Fairfield 2.945
Singapore 2.880
Ashburn 1.780
Ann Arbor 1.452
San Jose 1.386
Hong Kong 1.275
Chandler 1.230
Seattle 1.188
Cambridge 955
Dublin 896
Beijing 766
Medford 685
Jacksonville 560
Santa Clara 486
Rome 485
New York 478
Dearborn 458
Kraków 456
Council Bluffs 455
The Dalles 433
Los Angeles 355
Ho Chi Minh City 348
Lawrence 318
Tokyo 316
Zhengzhou 280
Lauterbourg 274
Hanoi 252
Moscow 227
Helsinki 200
Buffalo 195
Dallas 193
San Diego 176
Boardman 167
São Paulo 164
Chicago 146
Milan 107
Menlo Park 106
Colorado Springs 103
London 86
Jakarta 85
Shanghai 85
Redondo Beach 76
Nuremberg 75
Hangzhou 74
Monte Vista 72
North Bergen 72
Naples 64
Redwood City 63
Norwalk 62
Phoenix 61
Toronto 54
Munich 53
Guangzhou 52
Orem 52
Belo Horizonte 48
Rio de Janeiro 47
Cardiff 46
Palo Alto 46
Frankfurt am Main 45
Stockholm 45
Brooklyn 43
Warsaw 43
Jinan 42
Nanjing 42
Salt Lake City 42
Haiphong 40
Da Nang 39
Hefei 39
Montreal 39
Brussels 38
Poplar 38
Mülheim 37
San Francisco 37
Denver 36
Dong Ket 35
Lappeenranta 35
Verona 34
Chennai 33
Columbus 33
Atlanta 32
Brasília 31
Johannesburg 30
Seoul 30
Manchester 29
Falls Church 28
Mountain View 28
Detroit 27
Tashkent 27
Vienna 27
Baghdad 26
Kunming 26
Amsterdam 25
La Veta 25
Curitiba 24
Tampa 24
Boston 22
Elk Grove Village 22
Totale 84.099
Salva come PNG Salva come JPEG
Nome #
Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules 543
β2-Agonist Therapy in Lung Disease 535
An update on the pharmacotherapeutic management of lower respiratory tract infections 523
Awake thoracoscopic biopsy of interstitial lung disease 522
Vats lung reduction in patients with advanced emphysema 518
Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit 507
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis 505
Interaction between corticosteroids and muscarinic antagonists in human airways 503
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells 503
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 501
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 497
Thoracoscopic reduction pneumoplasty for severe emphysema: Do pleural adhesions affect outcome? 496
Surgery of giant emphysematous bullae 490
Effect of lung volume reduction surgery for severe emphysema on right ventricular function 488
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 488
Minimalist video-assisted thoracic surgery biopsy of mediastinal tumors 485
Completion lobectomy after bilateral lung volume reduction for emphysema: Salvage option or fancy? 484
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 484
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD 482
Glucagon-like peptide 1 receptor: A novel pharmacological target for treating human bronchial hyperresponsiveness 481
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD 479
An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply network 478
Airflow obstruction: Is it asthma or is it COPD? 474
Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol. 473
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment 473
Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation 473
Unilateral thoracoscopic reduction pneumoplasty for asymmetric emphysema 470
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside 470
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 466
Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. 464
High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. 463
Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase 461
Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update 461
Optimizing drug delivery in COPD: The role of inhaler devices 460
Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases 460
Combined pulmonary fibrosis and emphysema: 3D time-resolved MR angiographic evaluation of pulmonary arterial mean transit time and time to peak enhancement 459
Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab 459
Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma 458
Occupational allergy to horse allergens: More than exposure to horses! 458
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis 455
Completion lobectomy after bilateral lung volume reduction for emphysema: salvage option or fancy? 454
Asthma and comorbid medical illness. 454
Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease 453
Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules 452
Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis 451
The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators 450
Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: A point of view 449
Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents? 448
Can pet keeping be considered the only criterion of exposure to cat/dog allergens in the first year of life? 446
Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma? 446
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease 445
Umeclidinium for the treatment of chronic obstructive pulmonary disease 445
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease 445
Treatment options for moderate-to-very severe chronic obstructive pulmonary disease 444
Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients 443
Clinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract 443
Metabolic syndrome and risk of pulmonary involvement 442
Tiotropium formulations and safety: a network meta-analysis 441
Results of unilateral lung volume reduction surgery in patients with distinct heterogeneity of emphysema between lungs 440
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 435
Asthma and comorbid medical illness 435
Bronchodilator therapy for chronic cough 435
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema 434
How many systemic reactions to skin prick tests could be preventable in defined conditions? 432
Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity 431
QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary disease 431
Is allergic sensitization to siberian hamster preventable in high-risk individuals who are already sensitized or exposed to furry animals? 431
Role of muscarinic antagonists in asthma therapy 431
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 431
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298 430
Clinical effect of corticosteroids in asthma-affected horses: A quantitative synthesis 430
Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD 429
The Challenges of Precision Medicine in COPD 429
Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study 428
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways 428
Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in “real life”? 428
Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease 427
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD 427
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity. 426
The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils 426
An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? 426
New Treatments for COPD in the Elderly 423
The effect of indacaterol during an acute exacerbation of COPD 423
Dog allergen immunotherapy and allergy to furry animals 423
Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi 421
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 421
Translational study searching for synergy between glycopyrronium and indacaterol 419
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi 419
A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD 418
Chronic treatment with indacaterol and airway response to salbutamol in stable COPD 417
Biomarkers of lung damage associated with tobacco smoke in induced sputum 417
Bacterial lysates as a potentially effective approach in preventing acute exacerbation of COPD. 415
Comorbidities of asthma 415
The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease 415
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 414
Can the presence of cat/dog at home be considered the only criterion of exposure to cat/dog allergens? A likely underestimated bias in clinical practice and in large epidemiological studies 414
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study 414
Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study 413
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi 413
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity 412
Totale 45.226
Salva come PNG Salva come JPEG
Categoria #
all - tutte 267.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 267.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021697 0 0 0 0 0 0 0 0 0 0 483 214
2021/20223.246 202 278 87 73 105 322 422 149 182 301 279 846
2022/20233.538 466 250 122 394 271 903 321 208 316 36 161 90
2023/20241.769 353 46 131 37 128 376 110 200 59 69 31 229
2024/20259.740 297 1.970 989 476 313 424 805 526 885 1.022 1.061 972
2025/202614.537 1.088 931 1.735 1.276 1.618 664 2.081 1.941 2.042 1.141 20 0
Totale 103.115